West Pharmaceutical Services Inc
WST· NYSE
Released Jul 25, 2024, before the open
10-Q filed Jul 25, 2024, 25 days after period end · 0000105770-24-000066
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $702.10M | $753.80M | $771.30M | $723.60M |
| Net Income | $111.30M | $155.10M | $188.50M | $187.30M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $1.51 |
| $2.06 |
| $2.48 |
| $2.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.